Drugs / Gallium-67 Citrate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00477503 Comparator | May 2007 → Jul 2009 | brain neoplasm | M.D. Anderson Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gallium-67 Citrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00477503 ↗ |
| Known as | Ga-67 | “Gallium-67 Citrate (Ga-67)” NCT00477503 ↗ |
| Modality | Diagnostic / imaging agent | “Ga-67 citrate has been used to detect inflammation and tumors in other parts of the body, and researchers want to learn if it is also able to detect tumors in the brain and spinal cord.” NCT00477503 ↗ |